WELL Health Technologies Corp. (TSX: WELL) announced that its subsidiary WELLSTAR Technologies Corp. has completed its amalgamation with 1587818 B.C. Ltd., forming a Resulting Issuer that will trade on the TSX Venture Exchange under the ticker symbol "WSTR." Trading is expected to commence on October 1, 2026, subject to WELLSTAR satisfying all TSXV requirements. The transaction marks a significant step in WELLSTAR's evolution as an independent publicly listed healthcare technology company, while WELL Health retains control through its multiple voting share position.

Key Points

  • WELL Health Technologies Corp. (TSX: WELL) and its subsidiary WELLSTAR Technologies Corp. (expected TSXV: WSTR)
  • WELLSTAR has completed its amalgamation with 1587818 B.C. Ltd., creating a Tier 1 TSXV-listed Resulting Issuer
  • Total shares issued and outstanding: 77,223,308, comprising 35,603,308 subordinate voting shares and 41,620,000 multiple voting shares; WELL Health holds all multiple voting shares
  • Investors will be watching whether WSTR satisfies all remaining TSXV requirements ahead of the October 1, 2026 expected trading date

Amalgamation Structure and Share Consolidation Details

In completing the transaction, WELLSTAR consolidated its subordinate voting shares and multiple voting shares on a six-for-one basis, meaning every six shares of each class became one share of the same class. The 818 Financing, conducted concurrently, resulted in the issuance of 3,555,293 subordinate voting shares by 1587818 B.C. Ltd., adding 127 new public shareholders to the Resulting Issuer as defined under TSXV policies. The Resulting Issuer continues to operate under the WELLSTAR Technologies Corp. name and carries on WELLSTAR's existing business.

WELL Health's Continued Control Through Multiple Voting Shares

Following the consolidation and amalgamation, WELL Health Technologies Corp. holds all 41,620,000 multiple voting shares of the Resulting Issuer, maintaining majority control of WELLSTAR as a publicly traded entity. Of the 35,603,308 subordinate voting shares outstanding, 30,296,464 are subject to voluntary lock-up arrangements. The release states that shareholders who held their shares in registered form have received their Resulting Issuer shares accordingly, while those wishing to hold through a brokerage account are directed to contact their broker.

WELLSTAR's Position in Canadian Healthcare Technology

The company describes WELLSTAR as serving over 40% of Canadian practitioners with its suite of offerings, which includes billing and practice management systems, electronic medical records, digital health applications, and AI-enabled clinical tools. WELLSTAR operates as a majority-owned subsidiary of WELL Health, which itself owns and operates 275 clinics across Canada supporting more than five million annual patient visits. The listing on the TSXV as a Tier 1 issuer is positioned by the company as supporting WELLSTAR's continued growth and innovation in digital healthcare enablement.